Amneal Pharmaceuticals, Inc.
NYSE:AMRX
8.71 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 701.78 | 659.191 | 616.981 | 620.04 | 599.046 | 557.54 | 609.759 | 545.557 | 559.355 | 497.633 | 536.896 | 528.593 | 535.075 | 493.105 | 510.034 | 519.294 | 464.662 | 498.533 | 397.328 | 378.283 | 404.642 | 446.12 | 497.528 | 476.487 | 413.787 | 275.189 | 293.369 | 254.733 | 259.871 | 225.681 | 298.576 |
| Cost of Revenue
| 451.833 | 421.131 | 427.154 | 387.509 | 379.025 | 379.354 | 394.371 | 351.327 | 358.836 | 323.062 | 370.494 | 330.082 | 322.577 | 301.543 | 342.962 | 385.709 | 320.425 | 315.034 | 287.094 | 323.849 | 299.393 | 363.04 | 304.12 | 276.382 | 235.492 | 130.594 | 141.953 | 119.72 | 136.138 | 115.832 | 121.926 |
| Gross Profit
| 249.947 | 238.06 | 189.827 | 232.531 | 220.021 | 178.186 | 215.388 | 194.23 | 200.519 | 174.571 | 166.402 | 198.511 | 212.498 | 191.562 | 167.072 | 133.585 | 144.237 | 183.499 | 110.234 | 54.434 | 105.249 | 83.08 | 193.408 | 200.105 | 178.295 | 144.595 | 151.416 | 135.013 | 123.733 | 109.849 | 176.65 |
| Gross Profit Ratio
| 0.356 | 0.361 | 0.308 | 0.375 | 0.367 | 0.32 | 0.353 | 0.356 | 0.358 | 0.351 | 0.31 | 0.376 | 0.397 | 0.388 | 0.328 | 0.257 | 0.31 | 0.368 | 0.277 | 0.144 | 0.26 | 0.186 | 0.389 | 0.42 | 0.431 | 0.525 | 0.516 | 0.53 | 0.476 | 0.487 | 0.592 |
| Reseach & Development Expenses
| 37.096 | 39.298 | 46.564 | 42.261 | 38.619 | 40.334 | 43.269 | 51.646 | 51.569 | 53.562 | 53.016 | 50.554 | 54.229 | 51.764 | 57.161 | 46.653 | 49.122 | 37.649 | 53.025 | 40.711 | 50.527 | 58.024 | 60.534 | 47.4 | 54.382 | 48.785 | 46.226 | 48.016 | 52.11 | 39.419 | 43.513 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 151.717 | 0 | 67.281 | 84.436 | 71.236 | 78.075 | 53.003 | 25.121 | 26.966 | 27.44 | 26.938 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -77.633 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 116.462 | 112.595 | 109.003 | 113.006 | 105.57 | 102.096 | 102.158 | 100.071 | 98.806 | 98.665 | 97.224 | 91.397 | 86.157 | 90.726 | 84.687 | 83.12 | 80.944 | 77.976 | 74.084 | 63.797 | 67.281 | 84.436 | 71.236 | 78.075 | 53.003 | 25.121 | 26.966 | 27.44 | 26.938 | 27.702 | 31.126 |
| Other Expenses
| 4.36 | 4.072 | 0.411 | 1.157 | 0.012 | -1.224 | -1.465 | -1.32 | 6.939 | 2.122 | 6.633 | 3.871 | 4.032 | 0.794 | 0.488 | 0.898 | 0.571 | 0.633 | -0.197 | 0.446 | 0.149 | 1.107 | 2.123 | -1.014 | 0.791 | 0.948 | 0.024 | -0.093 | -0.078 | 0 | 0 |
| Operating Expenses
| 167.002 | 151.893 | 155.567 | 155.34 | 144.202 | 141.206 | 143.962 | 150.397 | 149.2 | 152.227 | 150.24 | 141.951 | 140.386 | 142.49 | 141.848 | 129.773 | 130.066 | 115.625 | 127.109 | 104.508 | 117.808 | 142.46 | 131.77 | 125.475 | 107.385 | 73.906 | 73.192 | 75.456 | 79.048 | 52.424 | 100.794 |
| Operating Income
| 95.47 | -10.746 | 14.193 | 75.648 | 80.084 | 34.449 | 74.198 | 44.353 | -198.618 | 23.305 | 11.175 | 28.515 | 67.119 | 45.907 | 20.178 | 2.435 | 10.751 | 57.791 | -23.135 | -112.274 | -18.913 | -94.36 | 23.28 | 74.555 | -181.062 | 63.554 | 79.019 | 78.753 | 44.603 | 42.728 | 92.297 |
| Operating Income Ratio
| 0.136 | -0.016 | 0.023 | 0.122 | 0.134 | 0.062 | 0.122 | 0.081 | -0.355 | 0.047 | 0.021 | 0.054 | 0.125 | 0.093 | 0.04 | 0.005 | 0.023 | 0.116 | -0.058 | -0.297 | -0.047 | -0.212 | 0.047 | 0.156 | -0.438 | 0.231 | 0.269 | 0.309 | 0.172 | 0.189 | 0.309 |
| Total Other Income Expenses Net
| 3.179 | -64.776 | -17.368 | -3.325 | 4.698 | -43.875 | -81.853 | -42.173 | -248.427 | -33.226 | 1.476 | -24.203 | -3.205 | -0.283 | 3.834 | 9.194 | 0.74 | -14.631 | -1.407 | 118.559 | 0.218 | -30.519 | -33.564 | -9.038 | -296.794 | 2.378 | 3.807 | -13.955 | 12.641 | 0.536 | -36.338 |
| Income Before Tax
| 20.405 | -75.522 | -83.461 | 22.957 | 29.66 | -9.426 | -7.655 | 2.18 | -232.731 | -9.921 | -16.319 | -2.043 | 34.824 | 14.904 | -5.477 | -21.889 | -21.758 | 13.344 | -57.111 | 26.276 | -56.227 | -133.18 | -14.806 | 22.574 | -262.506 | 52.016 | 62.075 | 26.384 | 39.6 | 43.264 | 55.959 |
| Income Before Tax Ratio
| 0.029 | -0.115 | -0.135 | 0.037 | 0.05 | -0.017 | -0.013 | 0.004 | -0.416 | -0.02 | -0.03 | -0.004 | 0.065 | 0.03 | -0.011 | -0.042 | -0.047 | 0.027 | -0.144 | 0.069 | -0.139 | -0.299 | -0.03 | 0.047 | -0.634 | 0.189 | 0.212 | 0.104 | 0.152 | 0.192 | 0.187 |
| Income Tax Expense
| 3.618 | 6.156 | 9.883 | -2.076 | -0.023 | 0.668 | -1.797 | 4.57 | 7.35 | -3.461 | 4.14 | 4.049 | 2.648 | 0.359 | 1.485 | 0.144 | 2.186 | -108.173 | 7.792 | 389.668 | -5.701 | -8.428 | 5.524 | 5.109 | -12.416 | 0.364 | -0.119 | -0.738 | 1.852 | 1.003 | 1.55 |
| Net Income
| 5.994 | -91.643 | -98.649 | 9.682 | 11.917 | -10.094 | -5.858 | -2.39 | -120.808 | -6.46 | -6.377 | -4.237 | 14.532 | 6.706 | -3.037 | -8.975 | -11.996 | 115.067 | -32.128 | -265.006 | -16.902 | -47.881 | -8.768 | 6.952 | -219.445 | 51.535 | 61.569 | 26.78 | 37.446 | 42.261 | 53.898 |
| Net Income Ratio
| 0.009 | -0.139 | -0.16 | 0.016 | 0.02 | -0.018 | -0.01 | -0.004 | -0.216 | -0.013 | -0.012 | -0.008 | 0.027 | 0.014 | -0.006 | -0.017 | -0.026 | 0.231 | -0.081 | -0.701 | -0.042 | -0.107 | -0.018 | 0.015 | -0.53 | 0.187 | 0.21 | 0.105 | 0.144 | 0.187 | 0.181 |
| EPS
| 0.02 | -0.3 | -0.4 | 0.06 | 0.08 | -0.066 | -0.039 | -0.016 | -0.8 | -0.043 | -0.043 | -0.028 | 0.1 | 0.05 | -0.021 | -0.061 | -0.081 | 0.78 | -0.23 | -2.03 | -0.13 | -0.37 | -0.069 | 0.05 | -1.73 | 0.45 | 0.54 | 0.23 | 0.33 | 0 | 0.29 |
| EPS Diluted
| 0.02 | -0.3 | -0.4 | 0.06 | 0.08 | -0.066 | -0.039 | -0.016 | -0.8 | -0.043 | -0.043 | -0.028 | 0.1 | 0.04 | -0.021 | -0.061 | -0.081 | 0.78 | -0.23 | -2.03 | -0.13 | -0.37 | -0.069 | 0.05 | -1.73 | 0.45 | 0.54 | 0.23 | 0.33 | 0 | 0.29 |
| EBITDA
| 142.877 | -10.746 | 50.799 | 135.554 | 132.942 | 98.669 | 135.254 | 111.15 | 117.954 | 82.281 | 83.978 | 60.431 | 132.632 | 105.415 | 25.712 | 64.069 | 72.814 | 126.59 | 37.231 | -49.628 | 38.296 | -9.405 | 63.761 | 116.629 | 103.847 | 86.388 | 91.09 | 71.422 | 44.607 | 53.328 | 102.011 |
| EBITDA Ratio
| 0.204 | -0.016 | 0.082 | 0.219 | 0.222 | 0.177 | 0.222 | 0.204 | 0.211 | 0.165 | 0.156 | 0.114 | 0.248 | 0.214 | 0.05 | 0.123 | 0.157 | 0.254 | 0.094 | -0.131 | 0.095 | -0.021 | 0.128 | 0.245 | 0.251 | 0.314 | 0.31 | 0.28 | 0.172 | 0.236 | 0.342 |